Yescarta Approved in Japan; Early Reimbursement Likely by March; UPDATED: Indications Table for CD19 CAR-T US Approvals and Submissions
Here is a brief preview of this blast: New content: The Celltelligence team has updated their CD19 CAR-T indications table for estimated approvals and submissions following presentations from JPM 2021 (see below for download).